Cellectar of Madison Wisconsin, is a radiopharmaceuticals company that designs and develops products to detect, treat and monitor a wide variety of human cancers.

News Update

Radiopharmaceutical production facility to support clinical development for lead drug candidate and other molecules.

Cellectar announces completion of a $13 million private offering for phase 1 clinical trial and continuing operations.

Cellectar announces the opening of a new, custom-designed radiopharmaceutical manufacturing facility in Madison, Wisconsin.

Cellectar announces the appointment of Ernest Allen as Director, Clinical Operations and LisaAnn Trembath as Manager, Medical Affairs.